{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:04:10Z","timestamp":1789513450704,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82241050"],"award-info":[{"award-number":["82241050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172125"],"award-info":[{"award-number":["82172125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018977","name":"Anhui Office of Philosophy and Social Science","doi-asserted-by":"publisher","award":["AHWJ2024Aa40017"],"award-info":[{"award-number":["AHWJ2024Aa40017"]}],"id":[{"id":"10.13039\/100018977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clnu.2026.106740","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:54:18Z","timestamp":1784789658000},"page":"106740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Elevated plasma glucagon-like Peptide-1 levels are associated with enteral feeding intolerance in traumatic brain injury"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4244-027X","authenticated-orcid":false,"given":"Haiyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyang","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangpin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur R.H.","family":"van Zanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2026.106740_bib1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","article-title":"Moderate and severe traumatic brain injury in adults","volume":"7","author":"Maas","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clnu.2026.106740_bib2","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1093\/brain\/awab255","article-title":"Metabolic derangements are associated with impaired glucose delivery following traumatic brain injury","volume":"144","author":"Hermanides","year":"2021","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.clnu.2026.106740_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101322","article-title":"The impact of exercise, sleep, and diet on neurocognitive recovery from mild traumatic brain injury in older adults: a narrative review","volume":"68","author":"Markovic","year":"2021","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.clnu.2026.106740_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00134-018-05517-6","article-title":"Boosting the injured brain with supplemental energy fuels","volume":"45","author":"Oddo","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clnu.2026.106740_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3171\/jns.1988.68.1.0062","article-title":"Intolerance to enteral feeding in the brain-injured patient","volume":"68","author":"Norton","year":"1988","journal-title":"J Neurosurg"},{"key":"10.1016\/j.clnu.2026.106740_bib6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1177\/0271678X241245486","article-title":"Neuroprotective effects of lactate and ketone bodies in acute brain injury","volume":"44","author":"Plourde","year":"2024","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.clnu.2026.106740_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the management of severe traumatic brain injury, fourth edition","volume":"80","author":"Carney","year":"2017","journal-title":"Neurosurgery"},{"key":"10.1016\/j.clnu.2026.106740_bib8","first-page":"12","volume":"vol. 46","author":"Compher","year":"2022"},{"key":"10.1016\/j.clnu.2026.106740_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clnu.2018.08.037","article-title":"ESPEN guideline on clinical nutrition in the intensive care unit","volume":"38","author":"Singer","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2026.106740_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaneurol.2025.0353","article-title":"GLP-1RA and SGLT2i medications for type 2 diabetes and alzheimer disease and related dementias","volume":"82","author":"Tang","year":"2025","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clnu.2026.106740_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/acn3.99","article-title":"GLP-1 improves neuropathology after murine cold lesion brain trauma","volume":"1","author":"DellaValle","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.clnu.2026.106740_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10753-020-01344-4","article-title":"GLP-1R agonist liraglutide attenuates inflammatory reaction and neuronal apoptosis and reduces early brain injury after subarachnoid hemorrhage in rats","volume":"44","author":"Tu","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.clnu.2026.106740_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","author":"Simon","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.clnu.2026.106740_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1159\/000529438","article-title":"Central GLP-1 resistance induced by severe traumatic brain injury was associated with persistent hyperglycemia in humans","volume":"113","author":"Zhou","year":"2023","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.clnu.2026.106740_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/379069a0","article-title":"A role for glucagon-like peptide-1 in the central regulation of feeding","volume":"379","author":"Turton","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.clnu.2026.106740_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/gut.44.1.81","article-title":"Glucagon-like peptide-1: a potent regulator of food intake in humans","volume":"44","author":"Gutzwiller","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2026.106740_bib17","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2026.106740_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2011.02.001","article-title":"Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation","volume":"13","author":"Hayes","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.clnu.2026.106740_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00125-023-06060-w","article-title":"GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion","volume":"67","author":"Gandasi","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2026.106740_bib20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.clnu.2026.106740_bib21","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1530\/EC-21-0130","article-title":"How glucagon-like peptide 1 receptor agonists work","volume":"10","author":"Andreasen","year":"2021","journal-title":"Endocr Connect"},{"key":"10.1016\/j.clnu.2026.106740_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes \u2013 state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metabol"},{"key":"10.1016\/j.clnu.2026.106740_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/neuros\/nyaa278","article-title":"Guidelines for the management of severe traumatic brain injury: 2020 update of the decompressive craniectomy recommendations","volume":"87","author":"Hawryluk","year":"2020","journal-title":"Neurosurgery"},{"issue":"89","key":"10.1016\/j.clnu.2026.106740_bib24","article-title":"Use a \u201cGHOST-CAP\u201d in acute brain injury","volume":"24","author":"Taccone","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.clnu.2026.106740_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00134-011-2459-y","article-title":"Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM working group on abdominal problems","volume":"38","author":"Reintam Blaser","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clnu.2026.106740_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.21037\/atm.2016.07.15","article-title":"Effectiveness of enteral feeding protocol on clinical outcomes in critically ill patients: a study protocol for before-and-after design","volume":"4","author":"Zhang","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.clnu.2026.106740_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13054-022-03921-5","article-title":"Actively implementing an evidence-based feeding guideline for critically ill patients (NEED): a multicenter, cluster-randomized, controlled trial","volume":"26","author":"Ke","year":"2022","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.clnu.2026.106740_bib28","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1097\/00003246-200110000-00018","article-title":"Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications","volume":"29","author":"Mentec","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clnu.2026.106740_bib29","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.clnu.2023.07.011","article-title":"ESPEN practical and partially revised guideline: clinical nutrition in the intensive care unit","volume":"42","author":"Singer","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2026.106740_bib30","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00134-013-2906-z","article-title":"Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the world society of the abdominal compartment syndrome","volume":"39","author":"Kirkpatrick","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clnu.2026.106740_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/bja\/aeu151","article-title":"Ultrasound assessment of gastric content and volume","volume":"113","author":"Van De Putte","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clnu.2026.106740_bib32","first-page":"149","article-title":"Diarrhoea in the critically ill","volume":"12","author":"Wiesen","year":"2006","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.clnu.2026.106740_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00134-016-4558-2","article-title":"The optimal target for acute glycemic control in critically ill patients: a network meta-analysis","volume":"43","author":"Yatabe","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clnu.2026.106740_bib34","article-title":"Serum total cholinesterase activity on admission is associated with disease severity and outcome in patients with traumatic brain injury","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2026.106740_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/30741","article-title":"Acute stress facilitates long-lasting changes in cholinergic gene expression","volume":"393","author":"Kaufer","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clnu.2026.106740_bib36","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1056\/NEJMoa1502826","article-title":"Permissive underfeeding or standard enteral feeding in critically ill adults","volume":"372","author":"Arabi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clnu.2026.106740_bib37","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.3390\/nu14224849","article-title":"Impact of energy and protein delivery to critically ill patients: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Nakanishi","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2026.106740_bib38","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/cc7874","article-title":"The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study","volume":"13","author":"Deane","year":"2009","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.clnu.2026.106740_bib39","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1186\/cc12795","article-title":"Impact of early versus late enteral nutrition on cell mediated immunity and its relationship with glucagon like peptide-1 in intensive care unit patients: a prospective study","volume":"17","author":"Bakiner","year":"2013","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.clnu.2026.106740_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/cc12758","article-title":"The gut-brain axis in the critically ill: is glucagon-like peptide-1 protective in neurocritical care?","volume":"17","author":"Plummer","year":"2013","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.clnu.2026.106740_bib41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s13054-015-1118-z","article-title":"The incretin effect in critically ill patients: a case-control study","volume":"19","author":"Nielsen","year":"2015","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.clnu.2026.106740_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114390","article-title":"GLP-1 as a regulator of sepsis outcomes: insights into cellular metabolism, inflammation, and therapeutic potential","volume":"152","author":"Fan","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.clnu.2026.106740_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molmet.2018.03.008","article-title":"Loss of dorsomedial hypothalamic GLP-1 signaling reduces BAT thermogenesis and increases adiposity","volume":"11","author":"Lee","year":"2018","journal-title":"Mol Metabol"},{"key":"10.1016\/j.clnu.2026.106740_bib44","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1210\/en.2016-1826","article-title":"Central nervous system GLP-1 receptors regulate islet hormone secretion and glucose homeostasis in Male rats","volume":"158","author":"Jessen","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.clnu.2026.106740_bib45","article-title":"Acute administration of interleukin-6 does not increase secretion of glucagon-like peptide-1 in mice","volume":"6","author":"Christiansen","year":"2018","journal-title":"Phys Rep"},{"key":"10.1016\/j.clnu.2026.106740_bib46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00005373-199806000-00016","article-title":"Intestinal permeability correlates with severity of injury in trauma patients","volume":"44","author":"Faries","year":"1998","journal-title":"J Trauma"},{"key":"10.1016\/j.clnu.2026.106740_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S2468-1253(18)30036-0","article-title":"Effects of enteral nutrition on gastrointestinal function in patients who are critically ill","volume":"3","author":"Sch\u00f6rghuber","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2026.106740_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s001340050809","article-title":"Effects of early enteral nutrition on intestinal permeability and the development of multiple organ failure after multiple injury","volume":"25","author":"Kompan","year":"1999","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clnu.2026.106740_bib49","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/nu8080502","article-title":"Partial enteral nutrition mitigated Ischemia\/reperfusion-induced damage of rat small intestinal barrier","volume":"8","author":"Wu","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2026.106740_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8815655","article-title":"Early enteral nutrition preserves intestinal barrier function through reducing the formation of neutrophil extracellular traps (NETs) in critically ill surgical patients","volume":"2020","author":"Hu","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.clnu.2026.106740_bib51","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0899-9007(01)00613-X","article-title":"Influence of polymeric enteral nutrition supplemented with different doses of glutamine on gut permeability in critically ill patients","volume":"17","author":"Velasco","year":"2001","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2026.106740_bib52","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2337\/db14-0100","article-title":"GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering","volume":"63","author":"Kahles","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2026.106740_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnu.2026.106740_bib54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fimmu.2016.00154","article-title":"Inflammation meets metabolic disease: gut feeling mediated by GLP-1","volume":"7","author":"Zietek","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnu.2026.106740_bib55","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.celrep.2017.10.008","article-title":"Enteroendocrine L cells sense LPS after gut barrier injury to enhance GLP-1 secretion","volume":"21","author":"Lebrun","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.clnu.2026.106740_bib56","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.cmet.2022.08.003","article-title":"Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation","volume":"34","author":"Wong","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.clnu.2026.106740_bib57","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1172\/JCI42497","article-title":"Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice","volume":"122","author":"Lamont","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1016\/j.clnu.2026.106740_bib58","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(22)02033-5","article-title":"LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial","volume":"400","author":"Urva","year":"2022","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.clnu.2026.106740_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074068","article-title":"Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"381","author":"Shi","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.clnu.2026.106740_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13811","article-title":"Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: a systematic review and meta-analysis","volume":"25","author":"Esparham","year":"2024","journal-title":"Obes Rev Off J Int Assoc Study Obes"},{"key":"10.1016\/j.clnu.2026.106740_bib61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clnu.2026.106740_bib62","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/cpt.2430","article-title":"Incretin-based drugs and risk of intestinal obstruction among patients with type 2 diabetes","volume":"111","author":"Faillie","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clnu.2026.106740_bib63","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.therap.2020.02.024","article-title":"Incretin-based drugs and intestinal obstruction: a pharmacovigilance study","volume":"75","author":"Gudin","year":"2020","journal-title":"Therapie"},{"key":"10.1016\/j.clnu.2026.106740_bib64","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s40261-022-01202-1","article-title":"Safety of glucagon-like peptide-1 receptor agonists: a real-world study based on the US FDA adverse event reporting system database","volume":"42","author":"Wu","year":"2022","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.clnu.2026.106740_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1043789","article-title":"Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: a real-world disproportionality study based on FDA adverse event reporting system database","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.clnu.2026.106740_bib66","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1474-4422(20)30182-4","article-title":"Clinical characteristics and outcomes in patients with traumatic brain injury in China: a prospective, multicentre, longitudinal, observational study","volume":"19","author":"Gao","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clnu.2026.106740_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155375","article-title":"Glucagon-like peptide-1 secretion in people with versus without type 2 diabetes: a systematic review and meta-analysis of cross-sectional studies","volume":"140","author":"Watkins","year":"2023","journal-title":"Metabolism"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426001676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426001676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:41:50Z","timestamp":1789512110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561426001676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":67,"alternative-id":["S0261561426001676"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106740","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated plasma glucagon-like Peptide-1 levels are associated with enteral feeding intolerance in traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106740"}}